Faron Pharmaceuticals Oy (FARN)

ORD NPV (DI)

Sell: 43.00p|Buy: 46.00p|Change: 0.50 (1.14%)

Open

44.00p

Previous close

44.00p

Trade high

46.00p

Volume

124,488

Year high

136.262p

Year low

22.7103p

Dividend yield

–

Market capitalisation

£51.52 mn

P/E ratio

–

ISIN

FI4000153309

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 31/03/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Faron Pharmaceuticals Oy	+ 1.14
More...

Company profile

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company. The company has one operating and reportable segment. The Group has a pipeline based on the receptors involved in the regulation of immune response in oncology, organ damage, and bone marrow regeneration. Faron is a late clinical stage drug discovery and development Group. The company includes Bexmarilimab in its pipeline. Bexmarilimab is Faron's wholly owned, investigational immunotherapy designed to overcome resistance to existing treatments and improve clinical outcomes by targeting myeloid cell function in the microenvironment and igniting the immune system against cancer.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
31/03/2026	04:39:50	44.25	25,000	11,062.50
31/03/2026	03:40:06	44.94999	4,440	1,995.78
31/03/2026	03:38:17	44.94999	1,991	894.95
31/03/2026	03:14:14	44.95	10,998	4,943.60
31/03/2026	02:55:16	44.7777	4,355	1,950.07

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.